← 25 Aug 2026 · Long-term Top 10 — Health Care
Long-term Top 10 — Health Care — what changed on 26 Aug 2026
A dated record of one session: what entered or left, what moved inside the ten and by how much, who is closest to the boundary, and how the list did against its benchmark. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100.
The long-term score is a published weighted sum of percentile ranks, rebalanced on the first trading day of each month. A list is a published formula and its output, not a recommendation. Method version 3.
Get this list's changes every morning
One short email a day: who entered, who left, and the reason — with the score moves behind it.
Informational only — not financial advice. One email a day, unsubscribe in one click.
Membership
No company entered or left on 26 Aug 2026. The next scheduled change is at this list's next rebalance.
Inside the ten
Against the previous session, 25 Aug 2026.
| Company | Rank | Score | Pillar that moved most |
|---|---|---|---|
| Lilly (Eli) (LLY) | 5 −1 | 69.3 −1.0 | Long-term trend 79th → 73rd |
| Amgen (AMGN) | 9 | 67.0 +0.1 | Valuation 32nd → 33rd |
| Johnson & Johnson (JNJ) | 16 | 64.6 +0.1 | Valuation 36th → 37th |
| ResMed (RMD) | 17 +1 | 64.1 +0.2 | Valuation 53rd → 54th |
| Bristol Myers Squibb (BMY) | 19 +1 | 63.4 −0.1 | no pillar moved materially |
| Royalty Pharma (RPRX) | 20 +1 | 62.9 +0.1 | no pillar moved materially |
| LIGAND PHARMACEUTICALS INC (LGND) | 21 +2 | 62.9 +0.2 | Long-term trend 70th → 71st |
| NATIONAL HEALTHCARE CORP (NHC) | 28 −4 | 61.2 −1.5 | Valuation 68th → 59th |
| Quest Diagnostics (DGX) | 30 | 60.6 +0.1 | Valuation 54th → 55th |
| West Pharmaceutical Services (WST) | 38 | 58.3 0.0 | Long-term trend 68th → 69th |
At the edge
Knocking
- AURINIA PHARMACEUTICALS INC (AUPH) scores 17.3 above the lowest member — the sector cap, not the score, is what is keeping it out
- Incyte (INCY) scores 15.5 above the lowest member — the sector cap, not the score, is what is keeping it out
Closest to the exit
- NATIONAL HEALTHCARE CORP (NHC) 3.8 below the score at rank 15, where the hold band ends
- Quest Diagnostics (DGX) 4.4 below the score at rank 15, where the hold band ends
- West Pharmaceutical Services (WST) 6.7 below the score at rank 15, where the hold band ends
Ranked against 199 eligible Health Care companies on this session. A company at the edge is a company near a boundary, not a prediction that it will cross one.
Against the benchmark
SPY is the S&P 500 ETF — the US large-cap market average.
−0.4% since the previous session (2026-08-25), against 0.0% for SPY — 0.4 points behind the benchmark. Tracked since 2026-08-18.
+1.5% since 2026-08-18, against −0.2% for SPY — 1.7 points ahead of the benchmark. Tracked since 2026-08-18.
Both curves are total return through 26 Aug 2026: a distribution buys more of the company that paid it, on the benchmark as much as on the list.
More
Informational only — NOT financial advice.